Lung Cancer Calu-3 Transfection Kit

Description

Lung cancer is the second most common cancer in the world. Lung cancer is continuously listed as one of the leading causes of death worldwide, for further research to find a definitive cure. Preclinical studies are necessary to understand the dynamics of lung cancer growth and its interaction with the immune system. The tumorigenic Calu-3 cell line, originally derived from the lung tissue of a 25-year-old Caucasian male with adenocarcinoma, has an epithelial morphology and is a suitable host for lung cancer-related research as well as other biomedical applications. The patient was treated with cystotoxin, bleomycin, and doxorubicin before decellularization. In order to facilitate in-depth research, a specific and efficient cell transfection system is essential. To this end, CD BioSciences has developed a specific transfection kit for the Calu-3 cell line.